Shandong Buchang Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 11.3% in First Three Quarters of 2021

Shandong Buchang Pharmaceuticals Co.,Ltd. (山东步长制药股份有限公司) (603858.SH) reported a net profit of 1.2 billion yuan in the first three quarters of 2021, down 11.3% year-on-year.

Meanwhile, the company posted 11.4 billion yuan in revenue, up 1.2% year-on-year.

At the end of the reporting period, it had 23.3 billion yuan in total assets and 8.9 billion yuan in total liabilities, with a liability-to-asset ratio of 38%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.